Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SGMS2 |
| Upstream (Parents) |
|---|
| (<<) ANTXR1 → SGMS2 |
| (<<) ATP2B4 → SGMS2 |
| (<<) AVP → SGMS2 |
| (<<) BCL2A1 → SGMS2 |
| (<<) BMP1 → SGMS2 |
| (<<) CDH11 → SGMS2 |
| (<<) CEP170 → SGMS2 |
| (<<) CFL2 → SGMS2 |
| (<<) CSGALNACT2 → SGMS2 |
| (<<) CXCR7 → SGMS2 |
| (<<) EIF4E → SGMS2 |
| (<<) ELF2 → SGMS2 |
| (<<) FGF1 → SGMS2 |
| (<<) GLS → SGMS2 |
| (<<) KRTAP1-3 → SGMS2 |
| (<<) MLXIPL → SGMS2 |
| (<<) NNMT → SGMS2 |
| (<<) PHLDA2 → SGMS2 |
| (<<) PLCH2 → SGMS2 |
| (<<) PRKCG → SGMS2 |
| (<<) RASSF5 → SGMS2 |
| (<<) RNF11 → SGMS2 |
| (<<) SULF1 → SGMS2 |
| (<<) THBS1 → SGMS2 |
| (<<) UGDH → SGMS2 |
| (<<) ZNF365 → SGMS2 |
| Downstream (Children) |
|---|
| SGMS2 → ARSJ (>>) |
| SGMS2 → CEACAM1 (>>) |
| SGMS2 → CSF2 (>>) |
| SGMS2 → ITGA2 (>>) |
| SGMS2 → JAG1 (>>) |
| SGMS2 → KLF10 (>>) |
| SGMS2 → PHLDA1 (>>) |
| SGMS2 → PLEK2 (>>) |
| SGMS2 → PROCR (>>) |
